NCT01484158

Brief Summary

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2001

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2001

Completed
10.2 years until next milestone

First Submitted

Initial submission to the registry

November 30, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2011

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
Last Updated

January 22, 2015

Status Verified

January 1, 2015

Enrollment Period

11.2 years

First QC Date

November 30, 2011

Last Update Submit

January 20, 2015

Conditions

Myocardial Infarction

Keywords

Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • Cardiovascular Events

    cardiovascular death, non-fatal myocardial infarction and non-fatal stroke

    5 years

Study Arms (1)

Myocardial Infarction

Patients with myocardial infarction

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with acute myocardial infarction.

You may qualify if:

  • Clinical diagnosis of ST-segment elevation acute myocardial infarction
  • Must be treated within 12 hours after symptom onset
  • Must be able to walk
  • Must receive successful primary percutaneous coronary intervention

You may not qualify if:

  • History of prior myocardial infarction
  • Cerebrovascular disease with residual hemiplegia
  • Severe peripheral arterial disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Matsuzawa Y, Konishi M, Akiyama E, Suzuki H, Nakayama N, Kiyokuni M, Sumita S, Ebina T, Kosuge M, Hibi K, Tsukahara K, Iwahashi N, Endo M, Maejima N, Saka K, Hashiba K, Okada K, Taguri M, Morita S, Sugiyama S, Ogawa H, Sashika H, Umemura S, Kimura K. Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction. J Am Coll Cardiol. 2013 May 14;61(19):1964-72. doi: 10.1016/j.jacc.2013.02.020. Epub 2013 Mar 14.

    PMID: 23500222DERIVED

Biospecimen

Retention: SAMPLES WITHOUT DNA

We retain only blood sample only in this study.

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Primary Investigator

Study Record Dates

First Submitted

November 30, 2011

First Posted

December 2, 2011

Study Start

October 1, 2001

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

January 22, 2015

Record last verified: 2015-01